Anubha Bajaj*
Department of Histopathology, Panjab University/A.B. Diagnostics, India
*Corresponding Author: Anubha Bajaj, Department of Histopathology, Panjab University/A.B. Diagnostics, India./p>
Received: August 24, 2023; Published: September 05, 2023
Adenocarcinoma in situ is designated as a cervical intraepithelial lesion constituted of glandular epithelium with a malignant countenance. Adenocarcinoma in situ manifests as a neoplastic glandular precursor of invasive endocervical adenocarcinoma. Untreated lesions display significant possible metamorphosis into invasive adenocarcinoma of uterine cervix. Employment of human papilloma virus (HPV) vaccine is associated with decimated disease incidence, especially in young females.
Citation: Anubha Bajaj. “The Indigenous Transmutation-Adenocarcinoma in situ Cervix" Acta Scientific Cancer Biology 7.8 (2023): 04-07.
Copyright: © 2023 Anubha Bajaj. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.